Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBI362 Phase 2 Trial in Overweight or Obese Adults
CTR20211220Phase 2Completed
- Sponsor
- Innovent Biologics
- Start
- Jun 2021
- Modality
- Hormonal Peptides → Native Peptides → Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of mazdutide in Overweight, obesity, sponsored by Innovent Biologics. Started Jun 2021; status: completed.
02
Drugs
mazdutide
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on CTR20211220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211220.